Jiaxin Peng

Wuhan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Single-cell transcriptomics identifies ergothioneine as a mitochondrial protector to prevent AKI-to-CKD progression.

Single-cell transcriptomics identifies ergothioneine as a mitochondrial protector to prevent AKI-to-CKD progression.

Journal: PloS one
Published: March 19, 2026

Evolutionary pattern of liquid-liquid phase separation in amphiphilic molecular self-assembly during the natural aging process of strong-aroma Baijiu.

Evolutionary pattern of liquid-liquid phase separation in amphiphilic molecular self-assembly during the natural aging process of strong-aroma Baijiu.

Journal: Food research international (Ottawa, Ont.)
Published: July 28, 2025

Senescence-Driven Remodeling Defines an Aggressive and Immunomodulatory Subtype of Endometriosis.

Senescence-Driven Remodeling Defines an Aggressive and Immunomodulatory Subtype of Endometriosis.

Journal: Aging cell
Published: July 13, 2025

Proteomic analysis reveals the potential mechanism of ergothioneine in preventing acute kidney injury to chronic kidney disease transition.

Proteomic analysis reveals the potential mechanism of ergothioneine in preventing acute kidney injury to chronic kidney disease transition.

Journal: Archives of biochemistry and biophysics
Published: April 20, 2025

Fluzoparib disrupts Golgi apparatus to inhibit O-GlcNAcylation and nuclear translocation of β-catenin to attenuate ovarian cancer invasion and metastasis.

Fluzoparib disrupts Golgi apparatus to inhibit O-GlcNAcylation and nuclear translocation of β-catenin to attenuate ovarian cancer invasion and metastasis.

Journal: International immunopharmacology
Published: April 03, 2025

NEK6 dampens FOXO3 nuclear translocation to stabilize C-MYC and promotes subsequent de novo purine synthesis to support ovarian cancer chemoresistance.

NEK6 dampens FOXO3 nuclear translocation to stabilize C-MYC and promotes subsequent de novo purine synthesis to support ovarian cancer chemoresistance.

Journal: Cell death & disease
Published: April 19, 2024

Novel LncRNA LINC02936 Suppresses Ferroptosis and Promotes Tumor Progression by Interacting with SIX1/CP Axis in Endometrial Cancer.

Novel LncRNA LINC02936 Suppresses Ferroptosis and Promotes Tumor Progression by Interacting with SIX1/CP Axis in Endometrial Cancer.

Journal: International journal of biological sciences
Published: May 16, 2023

HOXA1 promotes aerobic glycolysis and cancer progression in cervical cancer.

HOXA1 promotes aerobic glycolysis and cancer progression in cervical cancer.

Journal: Cellular signalling
Published: March 16, 2023

Burden of ovarian cancer in China from 1990 to 2030: A systematic analysis and comparison with the global level.

Burden of ovarian cancer in China from 1990 to 2030: A systematic analysis and comparison with the global level.

Journal: Frontiers in public health
Published: January 03, 2023

Purvalanol A induces apoptosis and reverses cisplatin resistance in ovarian cancer.

Purvalanol A induces apoptosis and reverses cisplatin resistance in ovarian cancer.

Journal: Anti-cancer drugs
Published: August 10, 2022

A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.

A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.

Journal: Frontiers in immunology
Published: May 13, 2022

Targeting purine metabolism in ovarian cancer.

Targeting purine metabolism in ovarian cancer.

Journal: Journal of ovarian research
Published: May 10, 2022
Showing 1-12 of 12

Last Updated: 09/26/2026